-
Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study
InCHEHC study group, 1 Apr 2023, In: The Lancet. Public health. 8, 4, p. e294-e304Research output: Contribution to journal › Article › Academic › peer-review
-
Liver-related complications before and after successful treatment of chronic hepatitis C virus infection in people with inherited bleeding disorders
Isfordink, C. J., van Erpecum, K. J., Fischer, K., van der Valk, P. R., van Vulpen, L. F. D., Schutgens, R. E. G., Arends, J. E. & Mauser-Bunschoten, E. P., Jan 2023, In: Haemophilia. 29, 1, p. 106-114 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Socio-economic factors associated with loss to follow-up among individuals with HCV: A Dutch nationwide cross-sectional study
van Dijk, M., Boyd, A., Brakenhoff, S. M., Isfordink, C. J., van Zoest, R. A., Verhagen, M. D., de Knegt, R. J., Drenth, J. P. H. & van der Valk, M., 2023, (E-pub ahead of print) In: Liver international.Research output: Contribution to journal › Article › Academic › peer-review
- All publications